• 1. Unsaturated lactones and mercaptans. Part III. Lactam of 2-(β-carboxyethyl)-2-methylthiazolidine-4-carboxylic acid from α-angelica lactone (pent-3-en-4-olide) and cysteine, and its n.m.r. spectrum
  Nils Hellstr?m,Sven-Olof Almqvist,Margarethe Aamisepp,S?ren Rodmar J. Chem. Soc. C 1968 392
• 2. Cysteine and carbonyl compounds. Part I. The dissociation of cysteine and its reaction with 4-oxopentanoic acid
  Nils Hellstr?m,Sven-Olof Almqvist,Margarethe Aamisepp J. Chem. Soc. B 1969 1103
• 3. An appraisal of the nutritional properties, therapeutic value, and novel implications of the under-utilized plant, Parkia speciosa
  K. Y. Foo RSC Adv. 2013 3 18248
• 4. Index of subjects, 1968
  J. Chem. Soc. C 1968 3115
• 5. Azafulvenium methides: new extended dipolar systems
  Oliver B. Sutcliffe,Richard C. Storr,Thomas L. Gilchrist,Paul Rafferty J. Chem. Soc. Perkin Trans. 1 2001 1795

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Research Brief on 2-Methylthiazolidine-4-carboxylic Acid (CAS: 4165-32-6): Recent Advances and Applications

2-Methylthiazolidine-4-carboxylic acid (CAS: 4165-32-6) is a thiazolidine derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. Recent studies have explored its role as a precursor in the synthesis of bioactive compounds, its antioxidant properties, and its potential in drug development. This research brief aims to provide an overview of the latest findings related to this compound, highlighting its chemical characteristics, biological activities, and emerging applications.

One of the key areas of interest in recent research is the compound's role in the synthesis of thiazolidine-based peptidomimetics. Thiazolidine rings are known to mimic peptide bonds, making them valuable in the design of protease inhibitors and other therapeutic agents. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that 2-Methylthiazolidine-4-carboxylic acid can serve as a versatile building block for the development of novel inhibitors targeting enzymes such as matrix metalloproteinases (MMPs), which are implicated in cancer metastasis and inflammatory diseases.

In addition to its synthetic utility, 2-Methylthiazolidine-4-carboxylic acid has been investigated for its antioxidant properties. Research published in Free Radical Biology and Medicine (2024) revealed that this compound exhibits significant radical scavenging activity, potentially offering protective effects against oxidative stress-related pathologies such as neurodegenerative diseases and cardiovascular disorders. The study utilized in vitro assays and molecular docking simulations to elucidate the mechanism of action, suggesting that the thiazolidine ring plays a critical role in neutralizing reactive oxygen species (ROS).

Another promising application of 2-Methylthiazolidine-4-carboxylic acid lies in its potential as a chelating agent for metal ions. A recent study in the Journal of Inorganic Biochemistry (2024) explored its ability to bind with transition metals such as copper and zinc, which are often dysregulated in various diseases. The findings indicated that the compound could be used to develop metal-chelating therapeutics for conditions like Wilson's disease and Alzheimer's disease, where metal ion homeostasis is disrupted.

Despite these advances, challenges remain in the practical application of 2-Methylthiazolidine-4-carboxylic acid. For instance, its stability under physiological conditions and bioavailability need further optimization. Recent work in the field of drug delivery has focused on formulating the compound into nanoparticles or conjugating it with biocompatible polymers to enhance its pharmacokinetic profile. A 2024 study in Advanced Drug Delivery Reviews highlighted the potential of such strategies to improve the therapeutic efficacy of thiazolidine-based compounds.

In conclusion, 2-Methylthiazolidine-4-carboxylic acid (CAS: 4165-32-6) represents a versatile and promising scaffold in chemical biology and pharmaceutical research. Its applications span from peptidomimetic design to antioxidant therapy and metal chelation, with ongoing studies addressing its limitations and expanding its potential uses. As research continues to uncover new facets of this compound, it is poised to play an increasingly important role in the development of next-generation therapeutics.

• 30097-06-4(Thiazolidine-2,4-dicarboxylic Acid)
• 14347-73-0(4-Thiazolidinecarboxylicacid, 2-ethyl-)
• 59411-63-1(4-Thiazolidinecarboxylic acid, 2-[2-[(2-amino-2-carboxyethyl)thio]ethyl]-)
• 58166-38-4((4R)-2,2-Dimethyl-4-thiazolidinecarboxylic acid)
• 115127-64-5(4-Thiazolidinecarboxylicacid, 2-(hydroxymethyl)-, (2R-cis)- (9CI))
• 88855-02-1(4-Thiazolidinecarboxylicacid, 2-methyl-, (2S,4R)-)
• 88855-03-2(4-Thiazolidinecarboxylicacid, 2-methyl-, (2R-trans)- (9CI))
• 124617-04-5(4-Thiazolidinecarboxylicacid, 2-(hydroxymethyl)-, (2S-trans)- (9CI))
• 213475-47-9(4-Thiazolidinecarboxylicacid, 2,2-dimethyl-, hydrochloride (1:1), (4S)-)
• 190062-99-8(4-Thiazolidinecarboxylicacid, 2-methyl-, (4R)-)